H-1B sponsorship profile: Revelio Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, Revelio Therapeutics, Inc filed 1 Labor Condition Applications covering 1 H-1B worker positions between fiscal year 2024 and fiscal year 2024. The employer’s DOL certification rate sits at 100% (1 certified of 1 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Revelio Therapeutics, Inc’s H-1B petitions range from $312,000 at the low end to $312,000 at the high end, with a petition-weighted average of $312,000. That range reflects the mix of occupations the company sponsors, led by Biochemistry Consultant (1 petitions at $312,000 avg). H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Revelio Therapeutics, Inc is headquartered in New York, NY under NAICS code 541714, and places H-1B workers across 1 state, most heavily in TN. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Revelio Therapeutics, Inc ranks. By H-1B petition volume, Revelio Therapeutics, Inc is #72,571 of 119,880 employers nationally and #8,544 of 14,719 employers headquartered in NY. Both ranks are computed live from the same underlying petition counts, not a separate estimate.